AU2016274238B2 - Bipyramid-templated synthesis of monodisperse noble metal nanocrystals - Google Patents
Bipyramid-templated synthesis of monodisperse noble metal nanocrystals Download PDFInfo
- Publication number
- AU2016274238B2 AU2016274238B2 AU2016274238A AU2016274238A AU2016274238B2 AU 2016274238 B2 AU2016274238 B2 AU 2016274238B2 AU 2016274238 A AU2016274238 A AU 2016274238A AU 2016274238 A AU2016274238 A AU 2016274238A AU 2016274238 B2 AU2016274238 B2 AU 2016274238B2
- Authority
- AU
- Australia
- Prior art keywords
- nanocrystals
- metal
- bipyramid
- nucleic acid
- reaction solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002159 nanocrystal Substances 0.000 title claims abstract description 334
- 229910000510 noble metal Inorganic materials 0.000 title abstract description 23
- 230000015572 biosynthetic process Effects 0.000 title description 20
- 238000003786 synthesis reaction Methods 0.000 title description 19
- 229910052751 metal Inorganic materials 0.000 claims abstract description 205
- 239000002184 metal Substances 0.000 claims abstract description 205
- 238000006243 chemical reaction Methods 0.000 claims abstract description 135
- 238000000034 method Methods 0.000 claims abstract description 99
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 69
- 239000010931 gold Substances 0.000 claims abstract description 59
- 229910052737 gold Inorganic materials 0.000 claims abstract description 49
- 108020004707 nucleic acids Proteins 0.000 claims description 79
- 150000007523 nucleic acids Chemical class 0.000 claims description 79
- 102000039446 nucleic acids Human genes 0.000 claims description 79
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 40
- 239000002073 nanorod Substances 0.000 claims description 35
- 230000005855 radiation Effects 0.000 claims description 33
- 238000010438 heat treatment Methods 0.000 claims description 32
- 239000000523 sample Substances 0.000 claims description 31
- 108090000790 Enzymes Proteins 0.000 claims description 29
- 102000004190 Enzymes Human genes 0.000 claims description 29
- 239000000377 silicon dioxide Substances 0.000 claims description 27
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 25
- 238000001228 spectrum Methods 0.000 claims description 25
- 239000000758 substrate Substances 0.000 claims description 25
- 230000003321 amplification Effects 0.000 claims description 23
- 239000000376 reactant Substances 0.000 claims description 21
- 239000011541 reaction mixture Substances 0.000 claims description 17
- 238000001816 cooling Methods 0.000 claims description 16
- 230000003287 optical effect Effects 0.000 claims description 15
- 230000001678 irradiating effect Effects 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 12
- 238000000576 coating method Methods 0.000 claims description 12
- 239000007850 fluorescent dye Substances 0.000 claims description 10
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 230000029087 digestion Effects 0.000 claims description 5
- 239000013612 plasmid Substances 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 3
- 239000002245 particle Substances 0.000 abstract description 28
- 239000000243 solution Substances 0.000 description 205
- 230000012010 growth Effects 0.000 description 121
- 239000004094 surface-active agent Substances 0.000 description 109
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 91
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 67
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 60
- SXPWTBGAZSPLHA-UHFFFAOYSA-M cetalkonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 SXPWTBGAZSPLHA-UHFFFAOYSA-M 0.000 description 44
- 229960000228 cetalkonium chloride Drugs 0.000 description 44
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 38
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 36
- 238000003917 TEM image Methods 0.000 description 28
- 238000005530 etching Methods 0.000 description 21
- 239000002105 nanoparticle Substances 0.000 description 21
- -1 silver ions Chemical class 0.000 description 20
- 229960005070 ascorbic acid Drugs 0.000 description 19
- 239000002243 precursor Substances 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 108020004414 DNA Proteins 0.000 description 17
- 239000011668 ascorbic acid Substances 0.000 description 17
- 235000010323 ascorbic acid Nutrition 0.000 description 16
- 230000001590 oxidative effect Effects 0.000 description 16
- 238000000746 purification Methods 0.000 description 16
- 239000003638 chemical reducing agent Substances 0.000 description 14
- 239000000693 micelle Substances 0.000 description 14
- 239000011258 core-shell material Substances 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 13
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 12
- 238000005189 flocculation Methods 0.000 description 12
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 208000012868 Overgrowth Diseases 0.000 description 10
- 230000016615 flocculation Effects 0.000 description 10
- 238000000584 ultraviolet--visible--near infrared spectrum Methods 0.000 description 10
- 230000007246 mechanism Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 230000001351 cycling effect Effects 0.000 description 8
- 239000012535 impurity Substances 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 238000003757 reverse transcription PCR Methods 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 238000006911 enzymatic reaction Methods 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 239000003002 pH adjusting agent Substances 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 7
- 238000004758 underpotential deposition Methods 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000008367 deionised water Substances 0.000 description 6
- 229910021641 deionized water Inorganic materials 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 230000001404 mediated effect Effects 0.000 description 6
- 229910052709 silver Inorganic materials 0.000 description 6
- 239000004332 silver Substances 0.000 description 6
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 238000000137 annealing Methods 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 239000000872 buffer Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 229910001961 silver nitrate Inorganic materials 0.000 description 5
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 4
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229910001882 dioxygen Inorganic materials 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000003760 magnetic stirring Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000002086 nanomaterial Substances 0.000 description 4
- 239000002077 nanosphere Substances 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 3
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 230000003416 augmentation Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 3
- GUAHPAJOXVYFON-ZETCQYMHSA-N (8S)-8-amino-7-oxononanoic acid zwitterion Chemical compound C[C@H](N)C(=O)CCCCCC(O)=O GUAHPAJOXVYFON-ZETCQYMHSA-N 0.000 description 2
- OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 2
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 239000008051 TBE buffer Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229910002056 binary alloy Inorganic materials 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 description 2
- 238000000024 high-resolution transmission electron micrograph Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000002082 metal nanoparticle Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000017066 negative regulation of growth Effects 0.000 description 2
- 230000006320 pegylation Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- 229910000077 silane Inorganic materials 0.000 description 2
- 150000003378 silver Chemical class 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 229910021642 ultra pure water Inorganic materials 0.000 description 2
- 239000012498 ultrapure water Substances 0.000 description 2
- IVNOJHSSOXLLSM-UHFFFAOYSA-N 2-pyran-2-ylidenepyran-3-carboximidamide Chemical compound NC(=N)C1=CC=COC1=C1OC=CC=C1 IVNOJHSSOXLLSM-UHFFFAOYSA-N 0.000 description 1
- 101710134784 Agnoprotein Proteins 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 108091060211 Expressed sequence tag Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229910003771 Gold(I) chloride Inorganic materials 0.000 description 1
- 229910003803 Gold(III) chloride Inorganic materials 0.000 description 1
- 229910004042 HAuCl4 Inorganic materials 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 238000007397 LAMP assay Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000020329 Zika virus infectious disease Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QZPSXPBJTPJTSZ-UHFFFAOYSA-N aqua regia Chemical compound Cl.O[N+]([O-])=O QZPSXPBJTPJTSZ-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 238000012170 cDNA-Seq Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000010415 colloidal nanoparticle Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000012053 enzymatic serum creatinine assay Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 230000003311 flocculating effect Effects 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- RJHLTVSLYWWTEF-UHFFFAOYSA-K gold trichloride Chemical compound Cl[Au](Cl)Cl RJHLTVSLYWWTEF-UHFFFAOYSA-K 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000010299 hexamethylene tetramine Nutrition 0.000 description 1
- 239000004312 hexamethylene tetramine Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 239000005351 kimble Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- NEYLGXVZJUUZMY-UHFFFAOYSA-K potassium;trichlorogold Chemical compound [K].Cl[Au](Cl)Cl NEYLGXVZJUUZMY-UHFFFAOYSA-K 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000034655 secondary growth Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 1
- 229940071536 silver acetate Drugs 0.000 description 1
- 229940096017 silver fluoride Drugs 0.000 description 1
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 1
- 229910000367 silver sulfate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229940071240 tetrachloroaurate Drugs 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- ANRASKQFUDPONQ-UHFFFAOYSA-M tributyl(hexadecyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](CCCC)(CCCC)CCCC ANRASKQFUDPONQ-UHFFFAOYSA-M 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- 238000001392 ultraviolet--visible--near infrared spectroscopy Methods 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F9/00—Making metallic powder or suspensions thereof
- B22F9/16—Making metallic powder or suspensions thereof using chemical processes
- B22F9/18—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds
- B22F9/24—Making metallic powder or suspensions thereof using chemical processes with reduction of metal compounds starting from liquid metal compounds, e.g. solutions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0553—Complex form nanoparticles, e.g. prism, pyramid, octahedron
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/02—Elements
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/10—Inorganic compounds or compositions
- C30B29/34—Silicates
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/10—Inorganic compounds or compositions
- C30B29/52—Alloys
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
- C30B29/60—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape characterised by shape
- C30B29/66—Crystals of complex geometrical shape, e.g. tubes, cylinders
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/005—Epitaxial layer growth
-
- C—CHEMISTRY; METALLURGY
- C30—CRYSTAL GROWTH
- C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
- C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions
- C30B7/14—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions the crystallising materials being formed by chemical reactions in the solution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/052—Metallic powder characterised by the size or surface area of the particles characterised by a mixture of particles of different sizes or by the particle size distribution
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y20/00—Nanooptics, e.g. quantum optics or photonic crystals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Metallurgy (AREA)
- Inorganic Chemistry (AREA)
- Nanotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Geometry (AREA)
- Manufacturing & Machinery (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Silicon Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562172481P | 2015-06-08 | 2015-06-08 | |
| US62/172,481 | 2015-06-08 | ||
| PCT/US2016/031522 WO2016200525A1 (en) | 2015-06-08 | 2016-05-09 | Bipyramid-templated synthesis of monodisperse noble metal nanocrystals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2016274238A1 AU2016274238A1 (en) | 2018-02-01 |
| AU2016274238B2 true AU2016274238B2 (en) | 2020-04-30 |
Family
ID=57504606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016274238A Active AU2016274238B2 (en) | 2015-06-08 | 2016-05-09 | Bipyramid-templated synthesis of monodisperse noble metal nanocrystals |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11045874B2 (https=) |
| EP (1) | EP3303662B1 (https=) |
| JP (2) | JP2018525305A (https=) |
| CN (1) | CN107849726B (https=) |
| AU (1) | AU2016274238B2 (https=) |
| CA (1) | CA2988553C (https=) |
| HK (1) | HK1253414A1 (https=) |
| WO (1) | WO2016200525A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3303662B1 (en) | 2015-06-08 | 2022-03-09 | The University of Chicago | Bipyramid-templated synthesis of monodisperse noble metal nanocrystals |
| KR20190091185A (ko) * | 2018-01-26 | 2019-08-05 | 서울대학교산학협력단 | 모서리 첨예도 지수가 조절된 금속 나노큐브의 제조방법 |
| CN108356278A (zh) * | 2018-03-01 | 2018-08-03 | 东南大学 | 一种表面等离激元纳米钉结构的规模化可控制备方法 |
| CN109128210A (zh) * | 2018-08-02 | 2019-01-04 | 黄河科技学院 | 一种哑铃状金纳米双锥/银纳米复合材料及其制备方法 |
| WO2020237017A1 (en) * | 2019-05-22 | 2020-11-26 | Promega Corporation | Methods using photothermal nanoparticles in rapid nucleic acid amplification and photothermal nanoparticles |
| CN110193608B (zh) * | 2019-06-06 | 2022-03-11 | 中国科学院合肥物质科学研究院 | 一种基于微刻蚀的从金纳米哑铃到金纳米颗粒的调控方法 |
| CN113275555B (zh) * | 2021-04-13 | 2022-04-19 | 南京航空航天大学 | 一种阵列结构的金属纳米框及其制备方法与应用 |
| CN113369492B (zh) * | 2021-06-09 | 2022-09-13 | 合肥工业大学 | 一种五重孪晶铂纳米棒及其制备方法 |
| CN113984685B (zh) * | 2021-09-30 | 2023-03-10 | 南京航空航天大学 | 一种银纳米结构生长机理的分析方法 |
| WO2023123134A1 (zh) | 2021-12-29 | 2023-07-06 | 长庚大学 | 核酸扩增方法及其装置暨核酸检测方法与其装置 |
| CN114309592B (zh) * | 2021-12-30 | 2025-01-10 | 杭州电子科技大学 | 一种在金纳米棒两端包覆二氧化硅的方法 |
| CN115901630B (zh) * | 2023-01-05 | 2023-06-06 | 武汉理工大学 | 一种氢敏反射膜片、制备方法及氢气浓度检测装置 |
| CN116559120A (zh) * | 2023-04-19 | 2023-08-08 | 大连海事大学 | 一种基于金双锥体纳米粒子的高灵敏度近红外lspr光纤生化传感器 |
| CN117300118B (zh) * | 2023-09-27 | 2026-03-31 | 浙江理工大学嵊州创新研究院有限公司 | 一种多组分复合异构纳米材料及其制备方法及应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020058258A1 (en) * | 1996-06-04 | 2002-05-16 | Wittwer Carl T. | Monitoring hybridization during PCR using SYBR Green I |
| US20070287660A1 (en) * | 1998-12-24 | 2007-12-13 | Council Of Scientific And Industrial Research | Novel clot-specific steptokinase proteins possessing altered plasminogen activation-characteristics and a process for the preparation of said proteins |
| CN103862036A (zh) * | 2014-01-24 | 2014-06-18 | 中国科学院长春光学精密机械与物理研究所 | 一种用于二氧化硅包覆贵金属纳米晶的制备方法 |
| US20140170664A1 (en) * | 2012-12-14 | 2014-06-19 | The Royal Institution For The Advancement Of Learning/Mcgill University | Heating mechanism for dna amplification, extraction or sterilization using photo-thermal nanoparticles |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009045579A2 (en) * | 2007-06-14 | 2009-04-09 | The Regents Of The University Of California | Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics |
| US9023372B2 (en) * | 2007-07-18 | 2015-05-05 | University Of Maryland | Metal-enhanced fluorescence nanoparticles |
| JP5264260B2 (ja) * | 2007-11-29 | 2013-08-14 | 国立大学法人九州大学 | 埋包微粒子の調製方法 |
| WO2010108158A2 (en) * | 2009-03-20 | 2010-09-23 | Northwestern University | Plasmon mediated, photoinduced synthesis of triangular bipyramids |
| CN101618461B (zh) * | 2009-08-12 | 2011-02-16 | 吉林大学 | 葫芦状、哑铃状或棒状金纳米粒子的制备方法 |
| US9410949B2 (en) * | 2010-12-03 | 2016-08-09 | Washington University In St. Louis | Label-free detection of renal cancer |
| DE102012201475B4 (de) * | 2012-02-01 | 2014-12-18 | Gna Biosolutions Gmbh | Verfahren zum Vervielfältigen von Nukleinsäuren |
| US9336919B2 (en) * | 2012-08-17 | 2016-05-10 | The Trustees Of The University Of Pennsylvania | Methods for preparing colloidal nanocrystal-based thin films |
| US9670380B2 (en) * | 2013-05-21 | 2017-06-06 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Chemical conversion process |
| CN103394704B (zh) | 2013-08-20 | 2015-09-30 | 纳米籽有限公司 | 高纯度金纳米双锥及其复合纳米材料的制备方法 |
| CN103566381A (zh) | 2013-10-30 | 2014-02-12 | 华东理工大学 | 一种多功能磁性纳米颗粒及其制备方法 |
| EP3303662B1 (en) | 2015-06-08 | 2022-03-09 | The University of Chicago | Bipyramid-templated synthesis of monodisperse noble metal nanocrystals |
-
2016
- 2016-05-09 EP EP16807983.8A patent/EP3303662B1/en active Active
- 2016-05-09 CA CA2988553A patent/CA2988553C/en active Active
- 2016-05-09 US US15/580,061 patent/US11045874B2/en active Active
- 2016-05-09 WO PCT/US2016/031522 patent/WO2016200525A1/en not_active Ceased
- 2016-05-09 CN CN201680042044.8A patent/CN107849726B/zh active Active
- 2016-05-09 AU AU2016274238A patent/AU2016274238B2/en active Active
- 2016-05-09 HK HK18112712.2A patent/HK1253414A1/zh unknown
- 2016-05-09 JP JP2017564023A patent/JP2018525305A/ja active Pending
-
2020
- 2020-12-16 JP JP2020208316A patent/JP7142958B2/ja active Active
-
2021
- 2021-03-18 US US17/205,140 patent/US11872635B2/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020058258A1 (en) * | 1996-06-04 | 2002-05-16 | Wittwer Carl T. | Monitoring hybridization during PCR using SYBR Green I |
| US20070287660A1 (en) * | 1998-12-24 | 2007-12-13 | Council Of Scientific And Industrial Research | Novel clot-specific steptokinase proteins possessing altered plasminogen activation-characteristics and a process for the preparation of said proteins |
| US20140170664A1 (en) * | 2012-12-14 | 2014-06-19 | The Royal Institution For The Advancement Of Learning/Mcgill University | Heating mechanism for dna amplification, extraction or sterilization using photo-thermal nanoparticles |
| CN103862036A (zh) * | 2014-01-24 | 2014-06-18 | 中国科学院长春光学精密机械与物理研究所 | 一种用于二氧化硅包覆贵金属纳米晶的制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| ROCHE, "Restriction Endonuclease Eco 47 III.", (2005), page 1, URL: https://pim-eservices.roche.com/LifeSciencelDocument/4f586893-97ed-e311-98a1-00215a9b0ba8 * |
| ZHOU, G et al., "Growth of nanobipyramid by using large sized Au decahedra as seeds.", ACS applied materials & interfaces., (2013), vol. 5, no. 24, pages 13340 - 44 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018525305A (ja) | 2018-09-06 |
| JP2021052786A (ja) | 2021-04-08 |
| JP7142958B2 (ja) | 2022-09-28 |
| US11872635B2 (en) | 2024-01-16 |
| WO2016200525A1 (en) | 2016-12-15 |
| EP3303662A4 (en) | 2018-12-05 |
| EP3303662B1 (en) | 2022-03-09 |
| HK1253414A1 (zh) | 2019-06-14 |
| AU2016274238A1 (en) | 2018-02-01 |
| CN107849726A (zh) | 2018-03-27 |
| EP3303662A1 (en) | 2018-04-11 |
| CA2988553A1 (en) | 2016-12-15 |
| US20180297120A1 (en) | 2018-10-18 |
| CN107849726B (zh) | 2021-07-13 |
| US11045874B2 (en) | 2021-06-29 |
| US20210276095A1 (en) | 2021-09-09 |
| CA2988553C (en) | 2022-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11872635B2 (en) | Bipyramid-templated synthesis of monodisperse noble metal nanocrystals | |
| He et al. | Recent advances of seed‐mediated growth of metal nanoparticles: from growth to applications | |
| Webb et al. | Geometry-dependent plasmonic tunability and photothermal characteristics of multibranched gold nanoantennas | |
| Shi et al. | A general approach to binary and ternary hybrid nanocrystals | |
| Díez et al. | Fluorescent silver nanoclusters | |
| Sanz-Ortiz et al. | Templated growth of surface enhanced Raman scattering-active branched gold nanoparticles within radial mesoporous silica shells | |
| Ma et al. | Au@ Ag core− shell nanocubes with finely tuned and well-controlled sizes, shell thicknesses, and optical properties | |
| Chang et al. | Silicon nanoparticles: Preparation, properties, and applications | |
| Jennings et al. | Past, present, and future of gold nanoparticles | |
| Liang et al. | Controlled synthesis of uniform silver nanospheres | |
| Kumar et al. | Biotemplated inorganic nanostructures: supramolecular directed nanosystems of semiconductor (s)/metal (s) mediated by nucleic acids and their properties | |
| Zhou et al. | Formation mechanism of chalcogenide nanocrystals confined inside genetically engineered virus-like particles | |
| Park et al. | Shape-dependent reversible assembly properties of polyvalent DNA–silver nanocube conjugates | |
| Lu et al. | Tris base assisted synthesis of monodispersed citrate-capped gold nanospheres with tunable size | |
| Karimi et al. | Controlled synthesis of colloidal monodisperse gold nanoparticles in a wide range of sizes; investigating the effect of reducing agent | |
| Piantanida et al. | Highly efficient gold nanoparticle dimer formation via DNA hybridization | |
| Qu et al. | Synthesis of tubular gold and silver nanoshells using silica nanowire core templates | |
| CN106620725B (zh) | 一种集光学和光声于一体的双模态分子影像探针及其制备方法和应用 | |
| Wazeer et al. | Nanomaterials synthesis via laser ablation in liquid: a review | |
| Liu et al. | Activation of Oxygen-Mediating Pathway Using Copper Ions: Fine-Tuning of Growth Kinetics in Gold Nanorod Overgrowth | |
| Fernández-Lodeiro et al. | Synthesis of tuneable gold nanostars: the role of adenosine monophosphate | |
| Kim et al. | Synthesis and thermodynamically controlled anisotropic assembly of DNA− silver nanoprism conjugates for diagnostic applications | |
| Lee et al. | DNA base pair stacking crystallization of gold colloids | |
| Shabalina et al. | Ag/SiOx nanocomposite powders synthesized from colloids obtained by pulsed laser ablation | |
| Liu et al. | Seed-mediated growth and manipulation of Au nanorods via size-controlled synthesis of Au seeds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |